Company Filing History:
Years Active: 2021-2023
Title: Hak Tak Claude Chan: Innovator in Immunomodulatory Antibodies
Introduction
Hak Tak Claude Chan is a prominent inventor based in Southampton, GB. He has made significant contributions to the field of immunology, particularly through his work on antibodies that have therapeutic applications. With a total of 2 patents, Chan is recognized for his innovative approaches to enhancing immune responses.
Latest Patents
Chan's latest patents focus on immunomodulatory antibodies. These inventions relate to antibodies specific for 4-1BB and OX40, which are crucial in modulating immune responses. The patents also detail methods for using these antibodies and their therapeutic applications, showcasing Chan's commitment to advancing medical science.
Career Highlights
Chan is currently associated with Cancer Research Technology Limited, where he continues to develop groundbreaking solutions in cancer treatment. His work is instrumental in bridging the gap between research and practical applications in immunotherapy.
Collaborations
Throughout his career, Chan has collaborated with notable professionals in the field, including Aymen Al-Shamkhani and Mark Steven Cragg. These collaborations have further enriched his research and contributed to the advancement of immunological therapies.
Conclusion
Hak Tak Claude Chan stands out as an influential inventor in the realm of immunomodulatory antibodies. His innovative patents and collaborations reflect his dedication to improving therapeutic strategies in cancer treatment.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.